chevron_leftBack
As of 13 June 2026, Synlogic, Inc. has a market cap of $7.49M USD, ranking #42747 globally and #5473 in the United States.
It ranks #3778 in the Healthcare sector, and #743 in the Biotechnology industry.
Key Stats
Market Cap
$7.49MUSD
Enterprise Value
-$7.18MUSD
EBITDA (TTM)
-$3.19MUSD
Net Income (TTM)
-$1.01MUSD
PB Ratio
0.6
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
CEO
Mary Dooley
open_in_new
Employees
1
Website
synlogictx.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0.8% | 0.9% | 4.6% | 6.7% | -64% | -45% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
SYBX
Synlogic Inc
ISIN: US87166L2097
Shares Out.:
Shares Outstanding:
11.697M1
Shares Float:
9.603M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
0.6400 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Synlogic, Inc.
Synlogic, Inc. does not have significant operations. It was previously engaged in the discovery and development of synthetic biotics to treat metabolic diseases. Synlogic, Inc. is based in Winchester, Massachusetts.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: AMGN
|
$182.42B
2M%
|
23.9
|
|
NASDAQ: GILD
|
$159.92B
2M%
|
19.0
|
|
NASDAQ: NTRA
|
$27.6B
369K%
|
-
|
|
NYSE: IQV
|
$26.3B
351K%
|
20.0
|
|
NASDAQ: UTHR
|
$25.03B
334K%
|
20.4
|
|
NASDAQ: MRNA
|
$18.13B
242K%
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
EBR: ARGX
|
$47.84B
639K%
41.39B EUR
|
39.9
|
|
KRX: 207940
|
$44.84B
599K%
68.19T KRW
|
35.5
|
|
ASX: CSL
|
$42.36B
566K%
60.27B AUD
|
29.3
|
|
SIX: LONN
|
$42.3B
565K%
33.71B CHF
|
37.2
|
|
KRX: 068270
|
$28.11B
375K%
42.76T KRW
|
43.8
|
|
NASDAQ: BNTX
|
$25.69B
343K%
|
-
|
chevron_leftBack